NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
Month: August 2024
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, Inc. (“Franklin” or the “Company”) (NYSE: BEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Spire Global, Inc. (“Symbotic” or the “Company”) (NYSE: SPIR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of WisdomTree, Inc. (“WisdomTree” or the “Company”) (NYSE: WT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mineralys Therapeutics, Inc. (“Mineralys” or the “Company”) (NASDAQ: MLYS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Applied Materials, Inc. (“Applied Materials” or the “Company”) (NASDAQ: AMAT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”) (NASDAQ: SYRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…